Sinopharm 1Q26 Net Profit RMB1.41 Billion, Down 3% YoY
I'm LongbridgeAI, I can summarize articles.
Sinopharmreported its 1Q26 results, revealing a net profit of RMB1.41 billion, a 3% decrease year-on-year. Revenue for the quarter was RMB140.77 billion, down 0.6% YoY, with earnings per share (EPS) at RMB0.45. The company's short selling amounted to $37.57 million, with a ratio of 26.901%.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: AASTOCKS News The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments